Pacific Biosciences Of California (PACB) Short-term Investments (2010 - 2026)

Pacific Biosciences Of California's Short-term Investments history runs 17 years deep, the most recent figure standing at $219.7 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 22.81% year-over-year to $219.7 million; the TTM figure through Mar 2026 stood at $219.7 million (down 22.81% YoY), while the FY2025 annual figure was $215.8 million, down 35.5% from the prior year.
• Short-term Investments was $219.7 million for Q1 2026 at Pacific Biosciences Of California, up from $215.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $620.6 million in Q2 2023 to a low of $300000.0 in Q3 2022.
• Historically, Short-term Investments has averaged $260.4 million across 5 years, with a median of $242.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments soared 196135.33% in 2022, then tumbled 99.94% in 2024.
• A 5-year view of Short-term Investments shows it stood at $447.2 million in 2022, then advanced by 0.96% to $451.5 million in 2023, then dropped by 25.9% to $334.6 million in 2024, then sank by 35.5% to $215.8 million in 2025, then gained by 1.8% to $219.7 million in 2026.
• The last three Short-term Investments figures came in at $219.7 million (Q1 2026), $215.8 million (Q4 2025), and $242.2 million (Q3 2025), per Business Quant data.